From 1 September 2026, the prescriber accreditation requirement for hepatitis B medicines under the PBS Section 100 (s100) Highly Specialised Drugs Program will be removed. As a result, all medical and authorised nurse practitioners will be able to prescribe hepatitis B antiviral treatment without additional specialist accreditation. ASHM is currently updating its website, education and resources to reflect this change.
Join us for a 90 minute networking event focused on strengthening hepatitis B care across primary and specialist settings. As we re-launch of the B-Referred project, we will showcase new resources designed to support clinicians in navigating referral pathways, assessing the suitability of primary care management, discussing care options with patients, and facilitating communication between […]
ASHM’s QLD HIV s100 Prescriber course will be delivered face-to-face over two days with online pre- and post-course activities. Attendance is free for practitioners residing in the targeted state or territory. Learning methods include online learning modules, presentations, case discussions and facilitated group work, allowing attendees to discuss practical strategies with peers and specialists. Upon […]
This workshop provides primary care clinicians with the knowledge, practical skills and resources to strengthen STI screening, diagnosis and management, with a focus on priority populations. It also explores strategies for preventing HIV transmission, including the role of HIV prevention and testing, and highlights the importance of timely contact tracing and partner notification in supporting […]
This two-day face to face training course helps nurses and midwives understand the public health aspects and clinical management of common STIs, HIV, hepatitis B and C. The course helps participants develop confidence in a proactive and practical approach to health care and evidence-based practice. This course is for healthcare professionals practicing in ACT. We […]
Syphilis rates have tripled in Australia over the past decade, highlighting the urgent need for greater awareness, screening and early intervention across a range of health and community settings. People accessing alcohol and other drug (AOD) services often face additional barriers to care and are at increased risk of sexually transmissible infections (STIs), including syphilis. Staff working in these […]
People accessing alcohol and other drug (AOD) services are disproportionately affected by hepatitis C, yet many continue to face barriers to testing, treatment and ongoing care. AOD services and needle and syringe programs are uniquely positioned to change this, playing a critical role in Australia’s hepatitis C elimination efforts. Join colleagues from across the AOD and health […]
This two-day face to face training course helps nurses and midwives understand the public health aspects and clinical management of common STIs, HIV, hepatitis B and hepatitis C. The course helps participants develop confidence in a proactive and practical approach to health care and evidence-based practice. This course is for healthcare professionals practicing in WA. […]
ASHM Head Office - Sydney
Level 3, 160 Clarence Street Sydney, NSW 2000
Tel: (+61) 02 8204 0700
ASHM acknowledges the Traditional Owners of Country across the various lands on which we live and work. We recognise Aboriginal and Torres Strait Islander peoples’ continuing connection to land, water, and community and we pay our respects to Elders past and present. ASHM acknowledges Sovereignty in this country has never been ceded. It always was, and always will be, Aboriginal land.
The information provided on this website and its related websites and guidelines, and the resources made available by ASHM in any format or medium, are for general information purposes only and are not intended as medical advice or as a substitute for consultation with a qualified healthcare professional. While ASHM Health strives to provide accurate and current resources and information, the resources, information and guidelines made available by ASHM Health do not provide personalised medical advice, diagnosis, or treatment. Healthcare professionals should apply their clinical judgment and consider individual circumstances when using this information. To the extent permitted by law, ASHM Health disclaims all liability for any outcomes resulting from reliance on the information provided. For specific medical concerns, please consult a licensed healthcare provider.
ASHM Health | ABN 48 264 545 457 | CFN 17788 | Copyright © 2026 ASHM